Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal MelanomaC. Mignard, P. Joly, L. Visseaux et al.|Journal of Oncology|2018Cited by 82
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case–control studyLéo Plaçais, Célèste Lebbé, Julie De Quatrebarbes et al.|Annals of the Rheumatic Diseases|2022Cited by 34